'Twinkle after-effect' can help retinal patients detect vision loss quickly and cheaplyOctober 29, 2007Boston, MA-Scientists at Schepens Eye Research Institute, an affiliate of Harvard Medical School, have discovered a simple and inexpensive way for patients with retinal and other eye disease to keep track of changes in their vision loss. In a study published in this week's PLoS ONE (October 24, 2007) they demonstrate that a compelling visual illusion known as the induced twinkle after-effect (TAE) can accurately identify the location and breadth of actual blind spots in people with retinal disease. The twinkle after-effect is a "twinkling" that people can see in a blind spot when they stare at a blank screen after staring at a noisy visual target such as a detuned television screen. "Our hope is that we can make this simple technique available online or on a DVD," says Dr. Peter Bex, associate scientist at Schepens Eye Research Institute and the principal investigator of the study. "This will be particularly helpful with patients who have glaucoma, diabetic retinopathy or macular degeneration where early detection of changes in vision can impact the effectiveness of treatments." According to Bex, many people fail to seek help when they develop blind spots in their vision, because their brains automatically compensate or "fill in" the missing information in their visual field. Since everyone has a blind spot where the optic nerve meets the retina, this perceptual "fill in" process is useful for normally sighted people, allowing them a complete visual image. "But this innate process can mask the effects of serious disorders such as diabetic retinopathy and glaucoma and keep sufferers from seeking help until the vision loss is very serious or they bump into objects they can no longer see." The traditional gold standard method for detecting blind spots (scotomas) is very expensive and time consuming and must be done in an ophthalmologist's office. The technique known as retinal specific microperimetry is a diagnostic tool that costs nearly 50 thousand dollars and requires specialized training to apply. In 1992 scientists became aware of what they eventually named the "twinkle after effect." They discovered that when someone looks at a television screen filled with static noise while covering part of their visual field with a small patch, the formerly patched area is left with a twinkling sensation after the noise is turned off and the person looks at a blank screen. The rest of the visual field does not experience the twinkling effect, which was described by one patient as resembling a moving cumulous cloud. "While this discovery was intriguing, it wasn't clear how it could be used for patients," says Bex. In the past several years, Bex and his team began to understand its potential. "We theorized that if people with blind spots stared at a noisy screen, the blind areas would "twinkle" when the screen was turned off and their eyes focused on a blank screen. These 'twinkling' blind spot areas could then easily be mapped," he says. To test their theory, Bex and his team asked eight patients with macular degeneration to undergo the retinal specific microperimetry test and his "twinkling after-effect" test. The team provided a blank touch screen--after the noisy screen--so patients could outline the twinkling areas with their finger. The team found that the results of the two tests matched in 75 percent of cases, and visual defects could be detected in areas that are not accessible to conventional microperimetry, confirming his belief that TAE could be used diagnostically. "This tool cannot replace the more sophisticated technique but we believe it is a powerful, simple tool that patients can use daily in the privacy of their home to detect any changes in their vision," he says. "If a patient detects a change, his or her physician can then study it more closely and offer therapy." While the results of this small study are very encouraging, Bex says the next step is to do a larger clinical study. Ultimately Bex sees this type of test being free to the public on the Internet or distributed through a public health entity. "We really believe this could have a great impact on the visual health of the community," says Bex. Public Library of Science |
|||||||||||||||||||||
| Related Vision Loss Current Events and Vision Loss News Articles Cataract surgery does not appear associated with worsening of age-related macular degeneration Age-related macular degeneration does not appear to progress at a higher rate among individuals who have had surgery to treat cataract, contrary to previous reports that treating one cause of vision loss worsens the other. Sight gone, but not necessarily lost? Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk Two studies are of particular note in today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer's disease; and new evidence from a Singapore National Eye Center study that diabetics who are nearsighted may be less susceptible to diabetic retinopathy. Treating ROP in tiny preemies; better glaucoma follow-up in urban clinic Highlights of today's Scientific Program of the 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting include: John T. Flynn, MD, Columbia University School of Medicine, discussing the ever-tougher challenges Eye M.D.s face in caring for the vision of the tiniest premature babies; and a report by Bradford W. Lee, MD, Stanford University School of Medicine, on barriers to glaucoma follow-up as perceived by patients in an urban, culturally diverse clinic. First in New York: Bionic technology aims to give sight to woman blinded beginning at age 13 A 50-year-old New York woman who was diagnosed with a progressive blinding disease at age 13 was implanted with an experimental electronic eye implant that has partially restored her vision. Experimental treatments restore partial vision to blind people Two experimental treatments, a retinal prosthesis and fetal tissue transplant, restored some vision to people with blinding eye diseases. The findings, presented at Neuroscience 2009, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news on brain science and health, may lead to new treatments for the blind. Cancer drug is no different in effectiveness as gold standard treatment for macular degeneration Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD). New device finds early signs of eye disease in preemies Tell-tale signs of a condition that can blind premature babies are being seen for the first time using a new handheld device in a study at Duke University Medical Center. Topical erectile dysfunction therapy shows promise An innovative drug-delivery system - nanoparticles encapsulating nitric oxide or prescription drugs - shows promise for topical treatment of erectile dysfunction (ED), according to a new study by scientists at Albert Einstein College of Medicine of Yeshiva University. Study predicts 40 percent increase in blindness in Nigeria by 2020 By 2020, 1.4 million Nigerians over age 40 will lose their sight, and the vast majority of the causes are either preventable or treatable, according to the Nigeria National Blindness and Visual Impairment Study Group. More Vision Loss Current Events and Vision Loss News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||